CDT Equity Inc. (CDT) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US20678X5023
CDT Equity Inc. financials
| Fiscal year | 2025 |
|---|---|
| Operating income | -36.76 m USD |
| EBIT | -39.02 m USD |
| Net income | -39.22 m USD |
| Diluted EPS – continuing operations | -1,177.89 USD |
Full history since 2021, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About CDT Equity Inc.
CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets. The company's pipeline includes AZD1656, a glucokinase activator that is in Phase II trials for the treatment of autoimmune disorders, including uveitis, Hashimoto's thyroiditis, preterm labor, and renal transplant; AZD5658, which is in Phase I clinical trial for the treatment of Type 2 Diabetes Mellitus; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It also provides treatments for inflammatory disorders, oncology, dermatology, rare diseases and animal health. The company was formerly known as Conduit Pharmaceuticals Inc. and changed its name to CDT Equity Inc. in August 2025. The company was founded in 2019 and is based in Naples, Florida.
More stocks
- STARGUIDE GROUP, INC. (STRG)
- Tenon Medical, Inc. (TNON)
- CYABRA, INC. (CYAB)
- AMERICAN REBEL HOLDINGS INC (AREB)
- MSP Recovery, Inc. (MSPR)
- QVC Group, Inc. (QVCG)
- Aditxt, Inc. (ADTX)
- RYAN SPECIALTY HOLDINGS, INC. (RYAN)
- Legence Corp. (LGN)
- PJT Partners Inc. (PJT)
- Hamilton Lane INC (HLNE)
- Andersen Group Inc. (ANDG)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.